HSIL lesion of the cervix uteri

N14_CERVICAL_HSIL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D06, N87.1, N87.2 Hospital discharge: ICD-9 — 6221B\|6221C\|2331A Cause of death: ICD-10 — D06, N87.1, N87.2 Cause of death: ICD-9 — 6221B\|6221C\|2331A 2 out of 7 registries used, show all original rules.	8207
4. Check minimum number of events None	8207
5. Include endpoints None	8207
6. Filter based on genotype QC (FinnGen only)	8207

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_CERVICAL_HSIL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N871\|N872\|D060\|D061\|D067\|D069
HD_ICD_9	6221B\|6221C\|2331A
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N871\|N872\|D060\|D061\|D067\|D069
COD_ICD_9	6221B\|6221C\|2331A
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to HSIL lesion of the cervix uteri based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	53171	53171	-
Only index persons	51989	51989	-
Unadjusted period prevalence (%)
Whole population	1.52	1.52	-
Only index persons	1.91	1.91	-
Median age at first event (years)
Whole population	-	34.59	-
Only index persons	-	34.40	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8207	8207	-
Unadjusted period prevalence (%)	2.80	2.80	-
Median age at first event (years)	35.09	35.09	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7298: Matched controls
72980

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N87.1

ICD-10 Finland

Moderate cervical dysplasia

16384.0

323.0

3559

ULA02

NOMESCO Finland

Kolposcopy

42.2

323.0

5673

5571

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

406.1

323.0

2289

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

14.6

323.0

4556

7471

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

137.3

323.0

4864

1044

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

38.4

323.0

5593

5736

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

9036.7

323.0

3796

C539, 6666, 0

ICD-O-3

216.4

323.0

1119

LDA10

NOMESCO Finland

Curettage of cervix uteri

19.2

323.0

2427

1850

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

+∞

323.0

381

N87.0

ICD-10 Finland

Mild cervical dysplasia

9.0

323.0

1040

1325

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

26.1

323.0

4218

3641

ZXC00

NOMESCO Finland

Use of diathermy

39.8

301.8

385

102

8070/2-C53.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of cervix uteri

83.5

283.2

319

A63.0

ICD-10 Finland

Anogenital (venereal) warts

5.1

273.7

950

2087

D06.1

ICD-10 Finland

Carcinoma in situ: Exocervix

+∞

254.7

243

8326

FHL

Batch conization

62.0

229.0

269

6221C

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]

+∞

217.8

208

6221B

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]

+∞

184.1

176

LEB00

NOMESCO Finland

Biopsy of vagina

8.2

183.4

428

547

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.0

168.0

3672

24614

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

9.8

159.4

334

354

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

310.8

149.2

151

G01AA10

ATC

clindamycin; vaginal

2.0

130.5

2013

11453

8077/2-C53.1

ICD-O-3

Squamous intraepithelial neoplasia, high grade of exocervix

265.2

127.5

130

D06.9

ICD-10 Finland

Carcinoma in situ: Cervix, unspecified

+∞

123.3

118

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

6.0

117.7

340

585

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

18.0

117.1

186

106

2331A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Cervix uteri

+∞

99.2

LDC00

NOMESCO Finland

Conisation of cervix uteri using knife

82.0

72.1

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

3.8

70.9

314

844

R87.2

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of other drugs, medicaments and biological substances

26.8

70.5

X86

ICPC

Abnormal cervix smear

5.2

70.5

227

445

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

9.2

63.1

135

149

R87.1

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of hormones

33.2

62.4

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

62.1

1270

7683

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

10.2

61.9

125

124

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

59.4

2361

17135

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

58.0

487

2028

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

20.5

52.6

P01AB01

ATC

metronidazole; oral, rectal

1.5

49.8

3112

24650

N89.1

ICD-10 Finland

Moderate vaginal dysplasia

15.3

47.5

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

46.7

1272

8296

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

24.8

41.8

Z3231

NOMESCO Finland

Registered nurse

1.5

41.1

1589

11261

D06BB04

ATC

podophyllotoxin; topical

1.9

41.1

617

3323

N89.2

ICD-10 Finland

Severe vaginal dysplasia, not elsewhere classified

19.8

40.4

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

17.3

37.9

N89.0

ICD-10 Finland

Mild vaginal dysplasia

7.6

36.7

115

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.6

36.6

1133

7591

Z2221

NOMESCO Finland

Medical doctor

1.4

34.4

2041

15691

Z3232

NOMESCO Finland

Midwife

1.5

34.2

1245

8660

TLC02

NOMESCO Finland

Simple extraction of IUD

1.9

32.8

540

2997

8140/2-C53.0

ICD-O-3

Adenocarcinoma in situ, NOS, of endocervix

+∞

32.3

WX110

NOMESCO Finland

Local anesthesy

1.3

29.5

4960

44666

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

12.8

29.2

8140/2-C53.1

ICD-O-3

Adenocarcinoma in situ, NOS, of exocervix

150.6

28.6

N90.1

ICD-10 Finland

Moderate vulvar dysplasia

11.9

28.3

O34.4

ICD-10 Finland

Maternal care for other abnormalities of cervix

8.8

28.3

SPAT1193

SPAT

Pap smear

1.5

28.3

1212

8694

N07BA03

ATC

varenicline; oral

2.0

28.2

385

1997

N87

ICD-10 Finland

Dysplasia of cervix uteri

17.0

27.9

N90.0

ICD-10 Finland

Mild vulvar dysplasia

8.2

27.2

R2110

NOMESCO Finland

Giving the first information

1.7

27.2

630

3892

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

26.8

2027

16101

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

8.7

26.4

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

3.2

26.3

141

445

8076/3-C53.9

ICD-O-3

Squamous cell carcinoma, microinvasive of cervix uteri

70.1

24.8

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

10.3

24.4

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

23.8

1155

8463

D06BB10

ATC

imiquimod; topical

2.0

23.6

318

1641

X23

ICPC

Fear sexually transm dis female

1.6

23.5

591

3728

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

23.4

798

5429

N76.0

ICD-10 Finland

Acute vaginitis

1.6

23.0

689

4548

8077/2-C52.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vagina, NOS

15.1

21.9

X92

ICPC

Chlamydia infection genital female

2.6

21.6

157

605

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

3.8

21.4

246

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.1

21.1

251

1234

LCH11

NOMESCO Finland

Pharmacologic abortion

1.6

21.0

522

3282

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

20.9

1686

13425

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

16.6

20.9

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.3

20.4

183

792

A63.8

ICD-10 Finland

Other specified predominantly sexually transmitted diseases

7.2

19.2

SPAT1283

SPAT

Restricted health certificate

1.3

18.8

1780

14475

8325

FHL

Coagulation, cryo or laser in anesthesia or operating room

6.0

18.5

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.8

18.5

304

1688

N02AX02

ATC

tramadol; systemic, rectal

1.3

17.9

2095

17499

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

17.9

594

4009

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

17.3

368

2217

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

17.1

368

2220

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.2

17.0

170

774

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

16.7

546

3671

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.3

16.6

1404

11210

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.9

16.4

228

1194

M03BX02

ATC

tizanidine; oral

1.2

16.4

4365

39905

SPAT1308

SPAT

Sexual health counselling

1.3

16.2

1408

11279

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.9

16.2

256

1404

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

16.2

905

6768

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

1.7

16.0

322

1909

R87.3

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of substances chiefly nonmedicinal as to source

33.4

15.7

8010/2-C53.9

ICD-O-3

Carcinoma in situ, NOS, of cervix uteri

+∞

15.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

15.5

5154

48100

G01AF01

ATC

metronidazole; vaginal

1.4

15.4

731

5303

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

3.4

15.2

211

Z72.0

ICD-10 Finland

Tobacco use

2.2

15.1

155

717

LCD10

NOMESCO Finland

Vaginal hysterectomy

1.9

15.0

234

1278

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.4

15.0

714

5187

N02BE01

ATC

paracetamol; systemic, rectal

1.3

14.9

5729

54205

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

14.9

2490

21581

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

4.3

14.8

126

M54.5

ICD-10 Finland

Low back pain

1.2

14.7

2128

18143

W11

ICPC

Contraception oral

1.4

14.5

923

7048

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

14.3

527

3638

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

14.2

1420

11564

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

14.2

549

3826

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

9.7

14.2

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

14.0

2794

24617

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

14.0

175

882

Z5132

NOMESCO Finland

Nursing associate professional

4.6

13.2

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.3

13.1

1010

7930

EBA00

NOMESCO Finland

Extraction of tooth

1.2

13.1

1886

16030

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

13.0

6572

63548

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.7

12.9

287

1750

8077/2-C51.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vulva, NOS

13.0

12.9

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

12.8

159

797

J01DB01

ATC

cefalexin; oral

1.2

12.6

5645

53588

N93.0

ICD-10 Finland

Postcoital and contact bleeding

2.6

12.5

349

J01CA08

ATC

pivmecillinam; oral

1.2

12.4

3454

31296

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

12.3

3342

30209

K02.1

ICD-10 Finland

Caries of dentine

1.2

12.2

4060

37367

R87.0

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of enzymes

6.7

12.2

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

12.1

1502

12537

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

11.9

3717

33976

D82

ICPC

Teeth/gum disease

1.2

11.9

2436

21413

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

11.8

263

1606

N06AX11

ATC

mirtazapine; oral

1.2

11.7

1857

15905

WX290

NOMESCO Finland

Other blockade of nerve

1.2

11.7

3352

30388

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

11.6

303

1932

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

11.5

1957

16883

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

11.5

2149

18719

X15

ICPC

Vaginal symptom/complaint other

1.6

11.3

326

2134

SPAT1312

SPAT

General health counselling

1.2

11.1

1981

17159

8070/3-C53.1

ICD-O-3

Squamous cell carcinoma, NOS, of exocervix

20.0

11.1

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

11.0

2471

21880

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

4.4

11.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

10.8

2438

21585

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

2.5

10.8

336

R74

ICPC

Upper respiratory infection acute

1.2

10.7

2364

20886

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

10.7

294

1901

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

10.6

100

449

SPAT1263

SPAT

Sampling

1.2

10.6

2645

23618

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

10.3

1374

11538

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

1.7

10.2

189

1096

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

1.8

10.1

158

872

W14

ICPC

Contraception female other

1.4

10.0

496

3625

8327

FHL

Amputation portionis and conization

40.1

10.0

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

9.9

3590

33014

N05CF01

ATC

zopiclone; oral

1.2

9.9

1503

12786

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

9.9

1026

8365

X85

ICPC

Cervical disease NOS

7.6

9.9

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

9.8

2338

20755

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

3.9

9.8

7950A

ICD-9 Finland

Nonspecific abnormal histological and immunological findings, Nonspecific abnormal Papanicolaou smear of cervix

8.7

9.8

J02AC01

ATC

fluconazole; systemic

1.2

9.7

3504

32185

C53.12

ICD-10 Finland

Adenocarcinoma of the exocervix

9.5

9.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

9.7

240

1514

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.6

4929

46572

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.4

9.6

383

2692

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

9.5

1239

10360

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

9.5

3576

32935

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

9.4

2175

19238

D06.7

ICD-10 Finland

Carcinoma in situ: Other parts of cervix

+∞

9.4

8077/2-C53.0

ICD-O-3

Squamous intraepithelial neoplasia, high grade of endocervix

+∞

9.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

9.3

2607

23430

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

9.3

1520

13018

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

9.2

1608

13861

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.3

9.2

638

4927

T74.1

ICD-10 Finland

Physical abuse

1.8

9.0

139

762

LDA96

NOMESCO Finland

Other biopsy of cervix uteri

15.6

9.0

J01AA02

ATC

doxycycline; systemic

1.2

9.0

4997

47369

A03

ICPC

Fever

1.2

8.8

1112

9263

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.5

8.8

112

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

5.1

8.7

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

8.7

551

4200

Z30.2

ICD-10 Finland

Sterilization

1.3

8.6

854

6916

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

8.4

1922

16953

M01AB05

ATC

diclofenac; systemic, rectal

1.2

8.3

4223

39619

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

8.3

1363

11666

LDA00

NOMESCO Finland

Dilatation of cervix uteri

2.3

8.2

304

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

0.8

8.1

818

9904

J01DA01

ATC

[U] cefalexin; systemic

1.2

8.0

4135

38776

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.5

8.0

235

21899

ICD-8 Finland

Uterine fibroma

0.2

7.9

368

WX002

NOMESCO Finland

Sedation and analgesia

1.3

7.8

794

6448

X29

ICPC

Genital sympt/compl female other

1.9

7.8

105

549

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.2

7.8

971

8069

J01FF01

ATC

clindamycin; systemic

1.2

7.8

1430

12365

SPAT1192

SPAT

Gynaecological examination

1.2

7.7

1072

9018

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.7

1188

10099

D11

ICPC

Diarrhoea

1.3

7.7

768

6229

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

7.4

7.7

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.3

7.6

276

J05AB01

ATC

aciclovir; systemic

1.2

7.6

1302

11182

N88.2

ICD-10 Finland

Stricture and stenosis of cervix uteri

4.9

7.6

L04AX01

ATC

azathioprine; systemic

1.5

7.5

221

1460

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

1.8

7.5

118

656

O34.3

ICD-10 Finland

Maternal care for cervical incompetence

2.3

7.4

268

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.1

7.4

4003

37567

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.3

7.3

584

4602

T810, N872

ICD-10 Finland

+∞

7.3

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

1.5

7.3

236

1595

N06AX16

ATC

venlafaxine; oral

1.2

7.3

931

7759

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

1.6

7.2

173

1086

X14

ICPC

Vaginal discharge

1.5

7.2

206

1350

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

0.8

7.2

392

5110

Z87.4

ICD-10 Finland

Personal history of diseases of the genitourinary system

2.0

7.1

401

LDC96

NOMESCO Finland

Other excision of cervix uteri

20.0

7.1

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

7.1

1548

13577

LDB10

NOMESCO Finland

Cryotherapy of cervix uteri

3.0

7.1

128

ZXC96

NOMESCO Finland

Robot assisted procedure

2.2

7.0

294

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.6

7.0

174

1104

XLA10

NOMESCO Finland

1.4

6.9

368

2726

R21

ICPC

Throat symptom/complaint

1.2

6.9

1576

13861

LCD30

NOMESCO Finland

Radical hysterectomy

6.3

6.9

X91

ICPC

Condylomata acuminata female

3.0

6.9

119

D10

ICPC

Vomiting

1.3

6.9

451

3456

L03

ICPC

Low back symptom/complaint

1.2

6.9

1385

12053

M54

ICD-10 Finland

Dorsalgia

1.3

6.9

674

5451

LDC10

NOMESCO Finland

Partial excision of cervix uteri

8.2

6.8

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

4.7

6.7

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.3

6.7

397

3001

8070/3-C53.0

ICD-O-3

Squamous cell carcinoma, NOS, of endocervix

22.5

6.7

A02BC02

ATC

pantoprazole; systemic

1.1

6.7

3646

34131

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

2.1

6.6

314

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

1.6

6.6

159

1000

N97.2

ICD-10 Finland

Female infertility of uterine origin

4.2

6.6

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

2.1

6.6

305

N05BA04

ATC

oxazepam; oral

1.2

6.6

1435

12570

Z2446

NOMESCO Finland

Social worker

1.4

6.6

302

2187

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

6.6

1668

14797

M77.1

ICD-10 Finland

Lateral epicondylitis

1.3

6.5

469

3641

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

6.5

997

8459

H02AB06

ATC

prednisolone; systemic

1.1

6.5

2546

23298

P17

ICPC

Tobacco abuse

1.9

6.5

424

SAA02

NOMESCO Finland

Basic examination of mouth

1.1

6.5

4672

44495

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

6.4

604

4860

1390

FHL

Colposcopy

4.2

6.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

6.4

1662

14764

W12

ICPC

Contraception intrauterine

1.2

6.3

1053

9003

R51.80

ICD-10 Finland

Headache

1.2

6.3

991

8427

8111

FHL

Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)

4.4

6.3

8140/3-C53.0

ICD-O-3

Adenocarcinoma, NOS, of endocervix

8.1

6.3

O04.1

ICD-10 Finland

Medical abortion, incomplete, complicated by delayed or excessive haemorrhage

1.8

6.3

508

4044

NOMESCO Finland

5.5

6.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

6.3

2514

23032

M01AH05

ATC

etoricoxib; oral

1.1

6.2

3616

33925

J01FA10

ATC

azithromycin; systemic

1.1

6.2

4174

39515

R05

ICPC

Cough

1.2

6.2

1253

10907

SPAT1301

SPAT

No procedures

1.2

6.1

1606

14267

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

6.1

872

7349

O63.0

ICD-10 Finland

Prolonged first stage (of labour)

0.6

6.1

1556

R87.8

ICD-10 Finland

Abnormal findings in specimens from female genital organs, other abnormal findings

2.9

6.0

123

6440A

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS IMMINENS]

1.7

6.0

125

759

M79.6

ICD-10 Finland

Pain in limb

1.1

6.0

2004

18115

AA1AD

NOMESCO Finland

CT of head and brain

1.2

6.0

764

6363

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

1.8

6.0

489

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1846

4597

4.89

307.65

2.3

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4677

22979

3.41

307.65

2.4

1.4

—

(3025130) Human papilloma virus identified in Specimen

1487

1766

10.06

307.65

2.3

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

626

434

15.53

307.65

2.4

1.7

—

(40768804) Tissue Pathology biopsy report

4612

29962

2.23

267.21

2.7

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2646

17940

1.70

100.49

2.4

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2384

15944

1.70

93.97

2.3

2.0

—

(4035726)

899

4734

2.01

75.65

1.4

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

148

5.59

43.29

1.6

2.2

ug/l

7.0

4.4

0.18

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1642

12021

1.46

37.36

2.0

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1288

9166

1.48

33.50

1.8

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

745

5351

1.43

17.79

1.6

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5245

48479

1.23

16.73

4.2

3.9

—

(3002256) Pathology report gross observation

1157

9025

1.33

16.53

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5069

46717

1.22

16.51

4.0

3.9

e6/l

1963.0

1858.5

0.03

479

(46235355) HIV 1 and 2 tests - Meaningful Use set

2798

24447

1.22

15.22

2.1

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5428

50885

1.20

12.75

4.0

3.7

mm/h

9.6

9.7

0.30

5119

48062

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7308

70716

1.31

12.37

11.0

10.1

mg/l

18.8

18.2

0.86

5643

54215

(42870588) Differential panel, method unspecified - Blood

2448

21448

1.20

12.28

6.1

5.8

—

(3044640) Blood type and Crossmatch panel - Blood

2457

21545

1.20

12.20

2.1

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

3868

35329

1.18

11.92

3.4

3.2

estimate

0.0

2.96

774

6967

(3023103) Potassium [Moles/volume] in Serum or Plasma

6994

67376

1.26

11.80

10.3

9.7

mmol/l

3.9

0.37

6780

65466

(3021601) Nitrite [Presence] in Urine by Test strip

3840

35094

1.18

11.64

4.5

4.4

estimate

0.0

0.00

790

7072

(3019550) Sodium [Moles/volume] in Serum or Plasma

6967

67182

1.25

11.04

10.3

9.6

mmol/l

139.5

139.6

2.05

6768

65442

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5133

48154

1.18

10.94

7.0

6.6

u/l

71.2

72.0

0.88

4833

45563

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1001

8089

1.27

10.68

2.2

u/l

4224.9

5999.1

1.19

396

3346

(3035350) Ketones [Presence] in Urine by Test strip

3809

34936

1.17

10.67

3.3

3.2

estimate

0.0

0.04

763

6842

(3006315) Basophils [#/volume] in Blood

3723

34226

1.16

9.79

5.9

5.7

e9/l

0.0

0.43

3302

30322

(3018095) Leukocytes [#/volume] in Urine

2450

21808

1.18

9.75

3.3

3.2

e6/l

58.2

74.4

0.97

1572

14089

(3011288) Drugs identified in Urine by Screen method

432

3174

1.38

9.06

4.0

2.5

—

(3001604) Monocytes [#/volume] in Blood

3698

34104

1.15

9.04

5.9

5.6

e9/l

0.5

0.75

3301

30297

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6584

63469

1.19

8.63

9.1

8.5

ml/min/173m2

92.3

92.1

0.43

5360

51830

(3006504) Eosinophils/100 leukocytes in Blood

3478

32005

1.15

8.62

6.1

5.6

2.7

2.8

0.82

3262

29995

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7527

73557

1.28

8.55

9.1

8.5

u/l

23.7

23.9

0.19

7321

71625

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3690

34122

1.15

8.48

3.9

3.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1804

15818

1.18

8.40

2.1

1.9

—

(3019069) Monocytes/100 leukocytes in Blood

3489

32167

1.15

8.31

6.3

5.9

7.8

7.9

0.12

3298

30414

(3030467) Casts [#/volume] in Urine by Automated count

1765

15482

1.18

8.15

2.9

2.7

e6/l

0.3

0.15

1283

11278

(3022096) Basophils/100 leukocytes in Blood

3352

30881

1.14

7.95

6.2

5.7

0.7

0.26

3137

28947

(3013115) Eosinophils [#/volume] in Blood

3820

35523

1.14

7.85

6.2

5.8

e9/l

0.2

0.10

3463

32067

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1074

9048

1.22

7.73

2.4

2.3

e6/l

1.0

1.2

0.69

572

4845

(3019198) Lymphocytes [#/volume] in Blood

3812

35467

1.14

7.72

5.9

5.6

e9/l

2.0

0.27

3453

32154

(3013650) Neutrophils [#/volume] in Blood by Automated count

4168

39024

1.14

7.63

8.4

8.3

e9/l

4.0

3.9

0.72

3702

34551

(3018010) Neutrophils/100 leukocytes in Blood

3567

33111

1.14

7.35

5.8

5.5

56.5

0.01

3360

31294

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3325

30737

1.14

7.28

5.4

5.2

umol/l

9.2

9.5

1.35

3114

28965

(3011397) Hemoglobin [Presence] in Urine by Test strip

1777

15723

1.17

7.26

3.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1346

11662

1.18

7.11

1.7

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

729

5963

1.24

6.96

2.2

2.7

u/ml

48.6

37.4

0.26

705

5765

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5290

50449

1.14

6.93

2.9

2.7

u/l

34.6

33.3

0.70

5061

48371

(3002030) Lymphocytes/100 leukocytes in Blood

3601

33537

1.13

6.88

6.1

5.6

29.7

29.8

0.22

3386

31599

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2905

26693

1.14

6.87

5.8

5.3

mmol/l

1.2

1.07

2471

22647

(3028707) Methadone [Presence] in Urine by Screen method

277

1988

1.41

6.76

3.4

2.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2602

23763

1.14

6.73

5.1

4.7

mmol/l

1.2

0.84

2365

21778

(3016879) Cocaine [Presence] in Urine

530

4200

1.28

6.63

2.8

1.9

—

(36304419) Bacteria [Presence] in Urine

1756

15621

1.16

6.61

2.8

2.6

—

(3002582) Erythrocytes [#/volume] in Urine

1905

17056

1.15

6.56

2.9

2.7

e6/l

39.2

72.8

1.43

1405

12649

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

996

8464

1.20

6.52

2.6

2.4

e6/l

4.8

5.0

0.13

495

4280

(3000764) Benzodiazepines [Presence] in Urine

570

4580

1.26

6.37

2.7

1.8

—

(3026008) Bacteria identified in Urine by Culture

2119

19146

1.14

6.37

2.5

2.4

—

(3029937) Albumin [Presence] in Urine by Test strip

2042

18430

1.14

6.21

3.7

3.5

estimate

0.0

0.02

792

6993

(3028300) Cannabinoids [Presence] in Urine

572

4620

1.26

6.12

2.8

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1635

14545

1.15

6.10

1.3

u/ml

11.4

9.1

0.72

639

6304

(3027008) Opiates [Presence] in Urine

569

4604

1.25

6.00

2.3

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

448

3526

1.29

5.94

3.0

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

1677

14972

1.15

5.94

3.6

3.3

98.1

98.8

0.59

1623

14488

(3024561) Albumin [Mass/volume] in Serum or Plasma

2591

23814

1.13

5.88

4.5

4.2

g/l

36.8

0.10

2440

22264

(40761511) CBC panel - Blood by Automated count

7633

75077

1.24

5.67

10.2

9.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

725

6064

1.21

5.61

4.5

4.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

387

1.84

5.59

1.2

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6936

67677

1.16

5.50

5.1

mu/l

1.7

2.0

3.48

6557

64526

(3021589) Normoblasts [#/volume] in Blood

3237

30243

1.12

5.42

8.3

7.9

e9/l

0.0

3.16

2677

24870

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2414

22196

1.12

5.34

1.7

1.8

pmol/l

99.3

99.8

0.18

1329

11884

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1083

9440

1.17

5.25

1.7

1.6

1.4

1.3

2.81

956

8557

(3027944) Amphetamines [Presence] in Urine

555

4559

1.23

5.14

2.5

1.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.12

4.90

1.4

—

(3007461) Platelets [#/volume] in Blood

8022

79502

1.40

4.89

16.5

15.3

e9/l

269.8

269.5

0.12

7886

78148

(3035941) MCH [Entitic mass]

8027

79562

1.41

4.87

16.4

15.2

30.2

30.0

31.78

7958

78927

(3024731) MCV [Entitic volume]

8027

79565

1.40

4.83

16.4

15.3

90.7

90.1

29.35

7956

78933

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

278

1.91

4.75

1.3

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

8027

79574

1.40

4.74

16.4

15.3

e12/l

4.4

4.5

13.47

7883

78138

(3010813) Leukocytes [#/volume] in Blood

8028

79591

1.40

4.68

16.5

15.4

e9/l

6.8

6.7

4.96

7885

78108

(3000963) Hemoglobin [Mass/volume] in Blood

8028

79606

1.39

4.52

16.5

15.4

g/l

133.0

0.01

7960

78964

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1667

15133

1.13

4.46

1.3

iu/ml

45.1

29.1

0.39

518

4725

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2085

19177

1.12

4.45

2.4

u/l

53.1

56.5

3.78

1927

17854

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6221

60510

1.12

4.31

4.4

pmol/l

14.3

0.18

5840

57175

(3026782) Osmolality of Urine

1213

10814

1.14

4.31

2.7

2.4

mosm/kgh2o

519.5

522.3

0.16

1027

9155

(3013826) Glucose [Moles/volume] in Serum or Plasma

3628

34379

1.10

4.27

4.0

3.8

mmol/l

6.2

6.3

0.87

3261

30878

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

228

1719

1.34

4.24

2.2

1.9

g/l

1.4

0.46

198

1493

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

576

4846

1.20

4.24

4.3

3.9

u/l

227.0

230.5

0.29

547

4591

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

300

2350

1.29

4.23

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1000

8807

1.15

4.23

1.3

iu/l

24.9

25.9

0.51

874

7734

(3023511) Choriogonadotropin [Units/volume] in Urine

505

4200

1.22

4.20

1.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1666

15181

1.12

4.16

1.9

2.0

u/l

178.5

137.9

0.72

1585

14415

(3032080) INR in Blood by Coagulation assay

1988

18321

1.11

4.05

4.8

5.1

inr

1.1

0.08

660

6195

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2928

27518

1.10

4.04

3.4

3.2

—

(3045414) Leukocytes [Presence] in Urine

384

3120

1.24

4.00

1.6

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

1297

11701

1.13

3.82

1.4

titre

549.6

566.2

0.11

269

2384

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

863

7592

1.15

3.72

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

463

1.60

3.69

1.6

promille

1.5

1.2

1.13

348

(3019832) Treponema pallidum Ab [Presence] in Serum

1857

17126

1.11

3.69

1.7

—

(40758558) Short blood count panel - Blood

1801

16587

1.11

3.67

6.2

6.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1983

18357

1.11

3.66

2.5

ng/l

29.9

69.2

0.46

794

7593

(3025941) Bacteria identified in Stool by Culture

569

4855

1.18

3.62

1.3

1.2

—

(3044889) 12 lead EKG panel

4333

41592

1.09

3.58

2.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2117

19686

1.10

3.56

3.0

3.1

mmol/l

2.3

0.22

1913

17775

(3019150) Specific gravity of Urine by Refractometry

1620

14864

1.11

3.54

3.5

3.4

kg/l

1.0

0.28

232

2269

(4198724)

438

1.60

3.51

4.9

2.1

—

(3000850) Epithelial cells [#/volume] in Urine

1309

11885

1.12

3.45

2.4

2.3

e6/l

9.2

8.6

0.42

1124

10272

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2247

20983

1.10

3.44

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

119

2.19

3.43

1.1

—

(3003181) Sodium [Moles/volume] in Urine

584

1.51

3.43

1.7

1.4

mmol/l

55.8

67.0

1.69

457

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.98

3.40

9.1

11.1

mmol/l

4.6

5.0

0.28

(3013762) Body weight Measured

7.00

3.36

1.0

—

(3018418) pH of Serum or Plasma

1730

16007

1.10

3.19

4.0

3.5

7.4

0.29

331

3050

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

450

1.56

3.17

2.3

1.7

100.1

101.8

0.13

401

(3014576) Chloride [Moles/volume] in Serum or Plasma

580

5024

1.17

3.11

7.3

6.2

mmol/l

104.7

104.9

0.41

570

4930

(3019225) pH of Specimen

565

4894

1.17

3.04

3.0

3.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6532

64038

1.10

2.94

3.4

3.5

mmol/l

5.6

0.94

6127

60424

(3027801) Oxygen [Partial pressure] in Arterial blood

495

4261

1.17

2.89

7.1

6.5

kpa

13.3

13.8

1.25

469

4069

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

495

4262

1.17

2.88

7.1

6.5

kpa

5.1

5.0

0.24

471

4074

(3042936) Bacteria identified in Isolate by Culture

873

7832

1.13

2.84

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1037

9412

1.12

2.76

2.4

mmol/l

2.4

0.04

905

8190

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

978

8853

1.12

2.73

2.7

2.8

ng/l

253.2

281.7

0.17

489

4503

(3048689) Calprotectin [Mass/mass] in Stool

1224

11216

1.11

2.73

2.5

2.4

ug/g

107.1

97.8

0.47

928

8804

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

733

6523

1.14

2.72

3.0

3.3

32.8

32.7

0.15

577

4928

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2444

23108

1.08

2.71

3.3

3.0

u/l

29.6

29.5

0.01

2318

22152

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

789

7061

1.13

2.68

3.1

2.4

umol/l

5.7

6.0

0.21

641

5905

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

635

5604

1.14

2.67

1.8

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

101

727

1.39

2.66

1.3

1.5

—

(3023368) Bacteria identified in Blood by Culture

1289

11859

1.10

2.65

3.9

3.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

147

1.91

2.64

1.1

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

147

1.91

2.64

1.1

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

847

7624

1.12

2.62

1.6

—

(3016502) Oxygen saturation in Arterial blood

427

3665

1.17

2.62

7.4

7.0

96.2

96.4

0.20

410

3507

(3002173) Hemoglobin [Mass/volume] in Arterial blood

410

3508

1.18

2.61

7.9

7.2

g/l

120.0

120.9

0.44

398

3372

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

199

1.76

2.59

2.9

2.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

222

1792

1.25

2.58

1.5

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

233

1892

1.24

2.57

10.2

8.3

mmol/l

24.2

0.01

217

1783

(3000991) Gas panel - Venous blood

382

3254

1.18

2.57

9.6

7.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

565

1.44

2.56

2.2

2.0

46.3

45.7

0.06

(3021879) Hepatitis B virus core Ab [Presence] in Serum

836

7535

1.12

2.53

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.03

2.52

1.1

1.2

ml/s/173m2

12.2

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

318

2672

1.20

2.51

1.4

u/l

20.9

24.7

1.42

240

2226

(3045424) Erythrocytes [Presence] in Urine

148

1143

1.30

2.48

1.3

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

6311

61906

1.08

2.48

13.1

12.3

13.4

13.5

1.12

6199

60775

(3022145) Colonoscopy Study observation

776

6980

1.12

2.44

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

292

2441

1.20

2.44

1.7

1.6

iu/ml

0.1

7.3

0.52

477

(3003396) Base excess in Arterial blood by calculation

491

4286

1.15

2.44

7.0

6.5

mmol/l

0.8

0.05

369

3241

(3003694) ABO and Rh group [Type] in Blood

2588

24607

1.08

2.44

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

272

2261

1.21

2.41

9.4

8.1

93.7

94.4

0.72

272

2250

(3004809) Band form neutrophils/100 leukocytes in Blood

682

1.38

2.40

3.2

2.5

1.3

1.4

0.14

541

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

553

4875

1.14

2.39

1.6

—

(3017732) Neutrophils [#/volume] in Blood

593

5258

1.14

2.36

2.5

2.3

e9/l

4.3

4.1

1.11

483

4471

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2116

19991

1.08

2.36

1.3

u/ml

1.7

1.5

0.37

626

5996

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

199

1607

1.24

2.34

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

244

2014

1.22

2.34

8.6

8.3

—

(4281824)

115

866

1.33

2.33

1.0

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

918

8368

1.11

2.28

1.7

nmol/l

1159.8

1196.0

0.63

732

6629

(3017354) Segmented neutrophils/100 leukocytes in Blood

406

1.48

2.25

3.5

2.4

57.2

56.3

0.10

260

(3021960) Folate [Moles/volume] in Serum or Plasma

1269

11761

1.09

2.25

1.4

nmol/l

21.3

21.2

0.09

1114

10483

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

335

2860

1.18

2.24

1.4

1.5

pmol/l

84.1

99.2

0.40

330

2793

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

556

1.41

2.23

1.2

1.3

u/ml

82.9

54.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

426

3708

1.16

2.23

1.7

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

253

2109

1.21

2.21

2.2

2.5

g/l

3.7

3.6

0.45

232

1988

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

557

1.40

2.21

1.2

1.3

u/ml

51.1

46.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

892

8138

1.11

2.19

3.2

3.0

mmol/l

0.8

0.72

838

7640

(3007164) IgA [Mass/volume] in Serum or Plasma

1772

16680

1.08

2.16

1.4

g/l

2.1

0.60

1088

10764

(21494890) Protein electrophoresis panel - 24 hour Urine

297

1.55

2.15

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.00

2.14

1.2

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

298

1.55

2.12

2.2

2.4

umol/l

126.5

174.6

0.72

148

(3041806) Other cells [#/volume] in Blood by Manual count

511

0.61

2.11

1.2

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

562

5006

1.13

2.11

1.0

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

537

1.40

2.11

1.2

1.3

u/ml

5.4

6.1

0.07

(3004789) Transferrin [Mass/volume] in Serum or Plasma

888

8119

1.11

2.10

2.4

2.2

g/l

2.4

2.5

2.13

801

7545

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

571

5094

1.13

2.09

2.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

172

1387

1.25

2.09

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

568

5070

1.13

2.07

2.5

g/l

10.5

0.18

520

4658

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

171

1380

1.24

2.07

2.9

3.3

u/ml

165.8

267.6

0.34

146

1179

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

557

4967

1.13

2.06

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

253

1.58

2.05

2.1

2.0

—

(4010399)

461

4064

1.14

2.04

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

168

1356

1.24

2.03

1.9

2.0

g/l

3.0

0.11

133

1069

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

139

1098

1.27

2.02

1.8

1.9

g/l

38.6

39.0

0.36

122

979

(3019060) Gas panel - Arterial blood

272

2305

1.19

2.02

3.4

4.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

147

1.77

2.01

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

165

1331

1.24

2.01

3.6

3.0

mg/l

1.4

1.3

0.37

158

1255

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

351

1.48

2.01

1.1

101.1

99.3

0.13

142

(3035320) C reactive protein [Mass/volume] in Body fluid

518

1.39

1.99

2.2

2.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

360

1.48

1.99

1.1

103.5

96.0

1.26

144

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

452

1.42

1.97

2.8

2.7

e6/l

814.3

910.3

0.46

198

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

142

1130

1.26

1.96

1.8

1.9

g/l

0.0

1.03

131

1041

(3010375) cycloSPORINE [Mass/volume] in Blood

225

1.60

1.95

22.9

25.7

ug/l

110.4

113.1

0.10

186

(36660697) Celiac disease serology panel - Serum

764

6964

1.11

1.93

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

237

1994

1.19

1.92

1.8

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

357

4092

0.87

1.92

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

573

1.36

1.91

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

307

2642

1.17

1.91

1.6

1.5

—

(40761536) Microorganisms panel - Urine sediment

701

6370

1.11

1.89

3.8

3.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

358

3120

1.15

1.89

1.5

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1407

1.23

1.87

1.9

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1407

1.23

1.87

1.9

2.0

g/l

3.7

0.20

130

1025

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1408

1.23

1.86

1.9

2.0

g/l

7.3

7.2

0.14

136

1092

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

219

1836

1.20

1.86

2.5

2.1

mg/l

10.5

10.2

0.31

210

1733

(40761535) Cells panel - Urine sediment

486

4330

1.13

1.85

3.4

3.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

333

1.47

1.85

3.2

3.0

mg/l

9.6

7.8

0.57

250

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.50

1.83

1.0

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

151

1223

1.24

1.81

2.2

2.1

g/l

0.6

0.5

0.18

136

1089

(3018677) aPTT in Platelet poor plasma by Coagulation assay

794

7279

1.10

1.81

2.0

2.1

29.2

29.1

0.24

770

7036

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

298

2575

1.16

1.78

2.6

2.0

g/l

0.2

0.61

279

2456

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

126

1002

1.26

1.78

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

126

1002

1.26

1.78

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

309

2679

1.16

1.77

1.8

1.9

ug/l

7.1

5.2

0.34

271

2337

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

496

4441

1.12

1.76

3.2

3.6

ug/l

6.1

22.5

1.17

366

3177

(3002179) Metamyelocytes/100 leukocytes in Blood

520

4670

1.12

1.75

4.1

3.8

0.9

0.6

0.38

106

813

(3012494) Peanut IgE Ab [Units/volume] in Serum

305

1.48

1.74

1.1

u/ml

2.1

2.5

0.09

163

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5866

57635

1.06

1.73

4.0

4.1

mmol/mol

36.8

37.4

5.77

5525

54736

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.92

1.72

7.3

3.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

437

3889

1.13

1.72

1.6

1.8

g/l

1.3

0.21

403

3611

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

306

2660

1.16

1.70

2.6

1.9

g/l

1.1

1.2

0.97

289

2545

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

256

2196

1.17

1.69

1.9

2.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

1.69

0.0

1.6

—

32.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

132

1063

1.25

1.69

2.7

2.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

520

4683

1.12

1.68

2.3

2.2

g/l

0.2

2.17

484

4438

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

366

1.42

1.67

1.2

1.1

122.3

117.7

0.36

324

(3042733) HLA Ab [Presence] in Serum

157

1.66

1.65

4.6

4.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2151

20569

1.06

1.63

3.0

2.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

127

1023

1.25

1.63

1.9

g/l

0.0

0.50

116

938

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

3.57

1.61

1.0

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1705

16192

1.07

1.61

2.1

mg/l

2.7

0.18

1460

14026

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

749

1.29

1.61

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

166

1379

1.21

1.60

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

112

892

1.26

1.59

2.7

3.2

mg/l

34.6

41.2

0.45

718

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

156

1290

1.21

1.58

2.0

g/l

10.5

10.2

0.31

134

1115

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

717

1.29

1.56

1.5

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

6921

68427

1.07

1.56

11.8

10.9

39.6

39.5

0.22

5723

56604

(3020650) Glucose [Presence] in Urine

223

1.53

1.56

1.1

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

974

9078

1.08

1.55

2.4

2.2

umol/l

14.9

14.5

0.98

890

8444

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

125

1013

1.24

1.54

1.9

g/l

0.0

0.00

115

936

(3010503) CD19 cells [#/volume] in Blood

381

1.39

1.54

3.0

2.5

e9/l

0.1

0.3

1.34

376

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.03

1.54

1.2

2.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

337

2975

1.14

1.53

1.3

1.2

—

(3013512) EKG study

1446

13681

1.07

1.53

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

146

1204

1.22

1.53

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

432

0.65

1.52

1.1

1.3

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

0.00

1.52

0.0

1.7

—

10.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

264

2295

1.16

1.50

1.5

1.6

u/ml

8.6

10.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

111

893

1.25

1.47

2.7

3.2

mg/l

27.4

38.6

0.81

720

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

781

7233

1.09

1.46

2.6

2.3

24.5

23.9

0.65

669

6278

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

314

2770

1.14

1.46

2.7

2.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

654

1.29

1.46

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

555

5062

1.10

1.45

4.3

4.0

0.7

0.9

0.37

140

1085

(3023183) Ammonium ion [Moles/volume] in Plasma

788

1.26

1.44

3.7

2.9

umol/l

31.6

33.1

0.38

684

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

762

1.26

1.43

1.4

—

(3010421) pH of Blood

143

1186

1.21

1.43

3.2

2.8

7.4

0.36

112

989

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

125

1.68

1.43

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

763

1.26

1.42

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

241

2769

0.87

1.42

1.1

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

339

3015

1.13

1.40

2.3

2.5

e9/l

71.3

72.0

0.11

255

2188

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

217

1872

1.16

1.39

1.5

1.7

titre

562.8

297.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

650

1.28

1.39

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

277

2433

1.14

1.39

1.9

2.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

458

5050

0.90

1.39

1.7

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

172

1457

1.18

1.38

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

117

955

1.23

1.38

2.9

2.8

mmol/l

24.9

24.2

1.17

100

842

(3021440) Promyelocytes/100 leukocytes in Blood

533

4869

1.10

1.36

4.4

4.1

0.1

0.2

1.31

134

1013

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

494

1.32

1.36

1.5

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.94

1.36

1.0

1.2

nmol/l

160.0

219.2

—

(21494755) Public health laboratory ask at order entry panel

1050

11158

0.93

1.35

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

258

2261

1.15

1.35

1.4

1.3

u/ml

15.0

7.0

0.72

234

(3025468) Yersinia sp identified in Specimen by Organism specific culture

761

1.25

1.33

1.4

—

(3022621) pH of Urine by Test strip

470

4274

1.11

1.32

2.7

2.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

218

1890

1.16

1.32

6.1

4.1

mmol/l

24.2

24.3

0.09

194

1685

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

562

5158

1.10

1.31

1.2

1.3

au/ml

25.5

36.7

1.40

212

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

261

2295

1.14

1.31

1.3

u/ml

7.0

8.4

0.30

380

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.09

1.30

1.0

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

773

1.24

1.30

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

104

845

1.23

1.30

3.2

2.4

kpa

8.9

8.8

0.20

790

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6838

67672

1.06

1.29

3.6

3.7

mmol/l

2.9

0.63

6480

64234

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.08

1.27

1.7

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6281

62017

1.05

1.27

3.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

588

1.28

1.27

1.7

1.9

mg/l

18.0

26.6

1.09

163

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.00

1.27

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

544

1.29

1.27

1.2

1.4

—

(3024928) Oxygen saturation in Venous blood

101

821

1.23

1.26

5.4

3.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

105

858

1.23

1.25

2.8

3.1

ratio

1.5

1.3

—

100

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1700

16270

1.06

1.25

1.7

mg/l

1.0

0.8

0.99

1256

12116

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

605

5586

1.09

1.25

2.3

au/ml

17.9

22.3

0.70

458

(3021447) Carbon dioxide [Partial pressure] in Venous blood

385

3478

1.11

1.25

4.5

3.6

kpa

5.9

5.8

0.27

377

3364

(3000494) Fungus identified in Specimen by Culture

787

7347

1.08

1.24

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

506

4636

1.10

1.24

11.6

12.2

inr

1.1

0.19

791

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.40

1.24

1.2

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

523

5691

0.91

1.23

1.4

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

389

3520

1.11

1.23

8.1

6.1

mmol/l

1.2

0.00

374

3403

(3007463) Buprenorphine [Presence] in Urine

1.97

1.22

14.5

4.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4101

40117

1.04

1.21

2.9

3.0

ug/l

72.9

67.0

1.54

3872

38261

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

322

1.37

1.20

2.3

2.8

42.1

46.3

—

115

(3002032) Base excess in Venous blood by calculation

381

3449

1.11

1.20

4.5

3.6

mmol/l

1.9

1.8

0.27

308

2791

(3000330) Specific gravity of Urine by Test strip

288

2567

1.13

1.19

3.0

2.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

285

2539

1.13

1.19

1.3

u/ml

36.6

35.5

0.04

183

(3014051) Protein [Presence] in Urine by Test strip

173

1491

1.16

1.17

1.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.70

1.17

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

198

1725

1.15

1.16

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

364

3294

1.11

1.16

9.6

7.0

mmol/l

7.8

7.1

1.22

345

3175

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.00

1.16

0.0

1.5

—

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

190

1.48

1.15

3.8

4.7

mg/l

6259.2

2794.0

0.23

136

(3009466) Valproate [Moles/volume] in Serum or Plasma

103

849

1.22

1.15

5.4

5.6

umol/l

376.4

374.5

0.04

724

(3021788) Differential panel - Synovial fluid

103

849

1.22

1.15

1.5

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.15

1.2

1.1

—

(3025159) Blasts/100 leukocytes in Blood

510

4695

1.09

1.15

4.3

4.1

0.1

0.2

0.21

108

873

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

777

1.23

1.15

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

158

1.52

1.14

1.2

1.1

nmol/l

0.4

0.10

105

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

778

1.22

1.13

1.1

1.2

—

(3011648) Oxygen content in Venous blood

326

1.35

1.13

2.3

2.4

10.6

10.8

0.17

326

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

101

833

1.22

1.13

1.1

g/l

1.5

0.02

762

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3034

29522

1.04

1.13

2.3

nmol/l

75.4

3032.1

0.50

2817

27729

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

242

1.41

1.11

1.4

1.7

au/ml

191.3

145.5

—

(40768446) Kidney Pathology biopsy report

192

1.46

1.11

1.9

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

503

1.27

1.10

3.0

2.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

620

5768

1.08

1.10

2.5

2.3

u/l

34.0

35.4

0.20

520

4928

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

993

9395

1.06

1.09

2.5

2.4

ng/l

658.6

577.7

0.50

811

7570

(3015171) Extractable nuclear Ab [Units/volume] in Serum

406

3710

1.10

1.09

1.3

u/ml

1.4

1.0

0.21

307

(3025315) Body weight

1.95

1.08

5.3

3.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

792

1.21

1.08

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

685

7323

0.93

1.08

1.6

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.19

1.08

1.6

1.3

nmol/l

320.3

535.4

—

(40768443) Skin Pathology biopsy report

242

2718

0.89

1.08

1.2

—

(3039000) Anion gap in Blood

107

893

1.20

1.07

4.3

6.5

mmol/l

11.1

0.10

797

(44813793)

675

1.23

1.07

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

121

1022

1.19

1.07

2.5

2.0

g/l

131.7

130.6

0.22

765

(3024354) Oxygen [Partial pressure] in Venous blood

308

2778

1.11

1.07

3.8

3.1

kpa

4.6

4.7

0.12

301

2676

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

299

2693

1.11

1.06

2.3

2.5

ng/l

138.0

107.8

0.63

264

2398

(3018572) Chloride [Moles/volume] in Blood

107

894

1.20

1.06

4.3

6.5

mmol/l

106.4

105.6

1.31

798

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.65

1.06

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

135

1573

0.86

1.03

1.1

au/ml

12.4

10.6

0.12

119

(3036180) Methadone [Presence] in Urine

2.27

1.03

3.4

2.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

317

2873

1.11

1.02

2.3

2.1

u/l

39.4

39.5

0.05

296

2697

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2261

21907

1.04

1.01

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

637

1.23

0.99

1.6

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

233

2080

1.12

0.99

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

133

0.53

0.98

1.3

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.67

0.97

1.6

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

201

1780

1.13

0.97

1.4

1.3

u/ml

2.5

3.0

0.11

130

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.97

0.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.74

0.96

1.7

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

114

970

1.18

0.95

2.1

1.7

iu/ml

32.2

35.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

199

1.41

0.95

1.0

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

183

1614

1.14

0.95

1.3

1.4

ug/g

332.6

313.5

0.50

101

825

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

0.00

0.95

0.0

1.0

—

0.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

614

1.22

0.94

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

503

4677

1.08

0.94

1.4

1.3

miu/ml

200.9

237.1

1.84

249

2414

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

183

1.42

0.93

1.8

2.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

200

1.40

0.93

2.8

2.7

ng/l

117.3

100.6

0.09

102

(40767503) Oxygen content in Capillary blood by calculation

105

890

1.18

0.92

2.9

2.1

17.0

16.8

0.26

430

(3027945) Reticulocytes/100 erythrocytes in Blood

480

4459

1.08

0.92

2.3

2.5

1.7

0.26

428

3991

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

458

4250

1.08

0.90

3.4

3.1

mmol/l

1.2

1.01

399

3728

(3008757) Leukocyte morphology finding [Identifier] in Blood

446

1.26

0.90

4.1

2.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

630

5918

1.07

0.90

6.5

4.9

mmol/l

1.0

0.46

595

5561

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

402

1.27

0.90

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.07

0.89

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

1208

0.85

0.89

1.4

1.5

g/l

0.5

0.6

0.93

918

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

114

1326

0.86

0.89

1.1

115.0

119.4

0.76

104

1218

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

301

0.70

0.88

1.1

u/ml

65.9

53.3

0.31

295

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.91

0.88

1.4

1.6

umol/24h

322.3

306.2

—

(3010937) Rubella virus Ab [Presence] in Serum

105

0.48

0.88

1.4

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

193

0.62

0.87

1.0

1.2

—

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

161

1.43

0.86

2.7

2.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

221

1.36

0.85

9.4

5.4

u/ml

48.2

2935.5

0.55

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

204

1.37

0.85

4.0

3.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6733

66785

1.05

0.84

3.4

mmol/l

1.6

0.08

6420

63722

(3000492) Spirometry study

737

6977

1.06

0.84

1.3

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.78

0.84

1.0

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

669

1.20

0.84

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

213

1.36

0.84

1.1

70.1

73.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

213

1.36

0.84

1.1

88.6

91.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

257

2334

1.10

0.83

5.3

6.4

mmol/l

24.2

24.3

0.16

242

2163

(3012501) Base excess in Blood by calculation

116

1002

1.16

0.83

3.4

2.8

mmol/l

2.0

2.2

0.28

618

(40760892) CBC W Ordered Manual Differential panel - Blood

1827

17698

1.04

0.83

4.1

3.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6765

67116

1.05

0.83

3.4

3.5

mmol/l

4.9

0.31

6459

64138

(3020891) Body temperature

166

1472

1.13

0.82

3.2

4.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

140

0.57

0.82

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.69

0.82

1.0

1.1

umol/24h

1.5

0.04

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

134

1172

1.15

0.82

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

1126

1.15

0.81

7.3

5.0

iu/ml

1004.1

849.0

0.13

127

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

181

1616

1.12

0.81

1.3

—

(3047181) Lactate [Moles/volume] in Blood

162

1437

1.13

0.80

3.9

5.0

mmol/l

1.2

0.21

146

1257

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

193

1732

1.12

0.79

3.8

3.2

1.6

1.3

1.77

193

1722

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

374

1.26

0.79

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

247

2247

1.10

0.79

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

139

1.44

0.79

3.4

2.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6475

64200

1.04

0.78

3.1

mmol/l

1.2

0.69

6147

61156

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.78

1.1

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

890

0.84

0.77

2.7

2.6

ug/min

53.6

79.9

0.48

569

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

313

1.28

0.77

1.7

1.9

mg/l

8.6

9.6

0.56

256

(1761868) Lipid panel - Serum or Plasma

2829

28914

0.97

0.76

2.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

227

1.32

0.74

1.2

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

679

1.18

0.74

6.3

3.7

60.2

62.4

0.41

679

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

188

1694

1.11

0.74

3.8

3.1

0.6

0.7

1.72

176

1625

(3027456) Digoxin [Moles/volume] in Serum or Plasma

289

1.28

0.73

2.6

3.1

nmol/l

0.8

0.07

217

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.84

0.73

2.0

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

133

1.43

0.73

1.1

—

(3006598) pH of Arterial cord blood

2.00

0.72

1.2

1.1

—

(3019174) dRVVT (LA screen)

100

1.50

0.72

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

340

3154

1.08

0.72

1.2

u/l

10.5

11.9

1.29

283

2643

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

256

2790

0.91

0.72

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

246

1.30

0.71

1.2

mmol/l

6.0

6.1

0.09

226

(3024891) Influenza virus A+B Ag [Presence] in Specimen

233

2128

1.10

0.71

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

154

1721

0.89

0.71

1.6

mmol/l

7.7

7.6

0.29

100

1064

(3030313) Adrenal Ab [Titer] in Serum

134

1.42

0.71

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.58

0.71

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

400

0.77

0.71

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

170

1528

1.11

0.71

4.3

4.8

0.9

1.08

160

1423

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1031

0.86

0.70

1.4

1.5

mmol/l

10.4

11.0

0.30

124

(42529406) Shigella sp [Presence] in Stool by Culture

248

2274

1.09

0.70

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

126

1.43

0.70

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

171

1539

1.11

0.70

4.3

4.7

1.9

1.7

0.84

160

1432

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

212

1.32

0.70

1.6

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

1531

14839

1.04

0.69

3.5

3.1

mmol/l

7.4

7.5

0.17

1323

12854

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

146

0.62

0.69

3.2

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

146

0.62

0.69

3.2

3.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

199

1808

1.10

0.68

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

338

3144

1.08

0.68

2.3

g/l

67.0

67.3

0.28

310

2907

(3009871) Measles virus Ab [Titer] in Serum

319

0.75

0.68

1.5

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

565

1.19

0.68

1.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.60

0.68

1.0

1.1

u/ml

0.1

0.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

127

1430

0.89

0.67

1.3

1.2

u/ml

2.9

4.1

1.09

575

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1148

11902

0.96

0.67

2.0

2.1

—

(3044009) aPTT.lupus sensitive (LA screen)

102

1.47

0.67

1.0

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.63

0.66

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

539

1.19

0.66

1.5

1.3

—

(3007916) DNA double strand Ab [Titer] in Serum

1.49

0.66

1.0

1.4

—

161.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

545

5160

1.06

0.66

1.5

1.4

—

(3021901) Oxygen saturation in Capillary blood

678

1.17

0.66

3.3

2.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

167

1509

1.11

0.65

1.4

1.3

u/ml

147.5

107.8

0.72

365

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

358

1.23

0.64

1.7

1.6

u/l

14.3

4.4

0.84

178

(3014765) Yersinia sp identified in Stool by Organism specific culture

246

2266

1.09

0.64

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

183

1663

1.10

0.64

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

413

1.21

0.64

1.3

1.5

e6/l

31232.4

33755.4

0.03

285

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

144

1292

1.12

0.64

2.5

2.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

127

0.63

1.1

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

536

0.82

0.63

17.1

16.8

nmol/l

1510.3

4627.0

0.79

514

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

207

1.31

0.63

1.6

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

198

1808

1.10

0.63

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

130

1161

1.12

0.63

1.3

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

225

1.29

0.63

1.1

1.2

106.3

107.5

0.10

212

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

190

1.32

0.62

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

190

1.32

0.62

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

190

1.32

0.62

1.0

—

(4306422)

125

1398

0.89

0.61

1.2

—

(40757373) Influenza virus identified in Isolate

105

0.57

0.61

1.0

1.4

—

(3008295) Osmolality of Serum or Plasma

498

1.19

0.61

1.6

1.8

mosm/kgh2o

280.6

282.6

0.29

406

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

233

0.73

0.60

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.48

0.60

1.8

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

122

1089

1.12

0.60

1.6

1.7

e6/l

6455.5

8456.5

0.70

820

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.60

0.0

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

177

1613

1.10

0.60

1.3

u/ml

19.3

20.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

218

1.29

0.60

1.1

1.2

—

(3034426) Prothrombin time (PT)

300

0.77

0.59

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

268

2489

1.08

0.59

2.4

2.1

iu/l

47.8

4.4

0.51

126

1066

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.59

0.0

11.1

—

(3006462) Nitrate [Presence] in Urine

317

1.23

0.59

2.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

509

0.82

0.59

1.0

1.1

miu/ml

1441.2

1505.7

0.14

509

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

949

0.87

0.58

3.8

4.3

u/ml

111.5

93.7

0.09

313

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

329

3082

1.07

0.58

1.5

—

(4211845)

355

1.21

0.57

2.6

2.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

248

2671

0.93

0.57

2.3

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

567

1.17

0.57

1.1

—

(40768441) Liver Pathology biopsy report

493

1.18

0.57

1.7

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

171

1561

1.10

0.57

1.3

1.2

u/ml

280.6

269.0

0.23

121

1053

(3013293) Extractable nuclear Ab [Presence] in Serum

158

1.33

0.57

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

818

0.87

0.56

1.4

g/l

0.4

0.30

577

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.57

0.56

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.51

0.56

2.7

2.2

—

(44806420)

1.45

0.56

2.9

2.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.56

0.55

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

112

1001

1.12

0.55

3.2

3.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

817

0.87

0.55

1.4

g/l

2.8

3.0

0.45

573

(3027135) IgG subclass 1 [Mass/volume] in Serum

817

0.87

0.55

1.4

g/l

6.9

6.6

0.22

575

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

606

1.16

0.55

1.6

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

516

0.83

0.55

13.5

11.9

nmol/l

861.0

836.7

0.15

496

(3013139) Helicobacter pylori Ag [Presence] in Stool

555

5292

1.05

0.55

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

569

5431

1.05

0.55

1.5

1.6

mu/l

285.2

314.1

1.06

508

4825

(3003338) MCHC [Mass/volume]

6362

64047

0.97

0.55

13.8

12.8

g/l

332.2

331.8

2.97

6318

63602

(40768797) Stomach Pathology biopsy report

909

8772

1.04

0.54

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

182

1674

1.09

0.53

2.8

2.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.54

0.53

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1496

14576

1.03

0.53

2.2

2.0

umol/l

1942.4

2497.9

0.41

1344

13068

(3018001) Oat IgE Ab [Units/volume] in Serum

1.43

0.52

1.0

u/ml

0.1

0.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

231

2483

0.93

0.52

1.2

—

(40768795) Lymph node Pathology biopsy report

563

1.16

0.52

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

780

0.87

0.52

1.5

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

403

0.82

0.52

1.1

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

106

950

1.12

0.51

3.1

3.9

u/ml

0.4

1.16

532

(3006653) Thiamine [Moles/volume] in Blood

359

0.81

0.51

1.3

1.5

nmol/l

124.6

130.6

0.34

359

(3047352) Trisomy 18 risk [Likelihood] in Fetus

497

5211

0.95

0.51

1.4

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

110

1221

0.90

0.50

3.8

3.3

mg/l

28.8

21.3

0.71

730

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

698

6712

1.04

0.50

1.4

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

596

0.85

0.50

1.1

u/l

1.0

0.77

242

(40759836) Histone Ab [Presence] in Serum by Immunoblot

697

1.13

0.50

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

497

5206

0.95

0.50

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

529

1.15

0.49

4.0

4.3

mmol/l

6.0

7.2

2.36

435

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

698

1.13

0.49

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

144

0.69

0.49

1.3

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

708

1.13

0.48

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

708

1.13

0.48

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

844

8156

1.04

0.48

1.2

iu/ml

175.9

151.9

0.71

335

3273

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

659

6337

1.04

0.48

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

206

1915

1.08

0.48

1.3

titre

122.6

155.3

0.18

185

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

655

6299

1.04

0.48

1.4

—

(3051651) Icteric interference index of Serum or Plasma

317

1.20

0.48

3.5

3.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

709

1.13

0.48

1.3

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

244

1.23

0.48

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

700

1.13

0.47

1.3

1.2

—

(4146454)

344

0.81

0.47

2.7

3.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

382

1.18

0.47

1.2

g/l

0.3

1.12

312

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1290

12567

1.03

0.47

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

134

1465

0.91

0.47

1.3

1.2

u/ml

3.6

3.1

0.13

490

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

663

1.13

0.47

1.6

2.0

u/ml

3.5

222.3

0.53

565

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

538

0.85

0.47

5.8

6.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.47

0.47

1.1

2.1

u/field

0.5

0.9

—

(3052592) Norovirus Ag [Presence] in Stool

1.41

0.46

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

100

1109

0.90

0.46

1.8

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

1.46

0.46

1.9

3.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

867

0.89

0.46

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

512

5347

0.95

0.46

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

111

1.35

0.46

1.5

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

152

1398

1.09

0.46

1.0

1.1

u/ml

0.2

0.3

0.09

288

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

657

6325

1.04

0.46

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

199

0.75

0.46

2.9

1.8

—

(3045142) Bone marrow Pathology biopsy report

402

1.17

0.46

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

816

1.12

0.46

1.2

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.60

0.45

1.8

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

264

1.21

0.45

1.7

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.45

1.0

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

117

1283

0.91

0.44

2.4

1.9

ug/l

4.8

1.7

0.89

1130

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

220

0.77

0.44

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

658

6342

1.04

0.44

1.4

—

(3008898) HLA-B27 [Presence]

435

4155

1.05

0.44

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1170

12008

0.97

0.44

3.3

mg/l

399.9

504.1

0.32

729

7282

(3020874) Milk IgE Ab [Units/volume] in Serum

734

1.12

0.43

1.0

1.1

u/ml

0.3

1.4

1.03

194

(3045683) HLA typing for celiac disease panel - Blood or Tissue

668

1.12

0.43

1.0

—

(3035880) pH of Pleural fluid

104

1.35

0.43

1.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

151

0.73

0.42

1.8

1.6

—

(40768806) Pleura Pathology biopsy report

218

0.78

0.42

1.4

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

658

6352

1.04

0.42

3.4

pmol/l

4.6

4.5

0.52

590

5751

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.38

0.42

1.3

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

257

2424

1.06

0.42

3.2

2.7

kpa

5.2

5.1

1.92

236

2272

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

309

3256

0.95

0.41

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

669

0.88

0.41

1.1

1.2

u/ml

0.1

0.9

1.60

250

(40768793) Breast Pathology biopsy report

215

2290

0.94

0.41

1.2

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

680

1.12

0.41

2.7

3.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.41

0.0

2.3

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

931

0.90

0.41

1.1

—

28.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

931

0.90

0.41

1.0

1.1

—

75.9

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.40

0.0

1.7

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.40

0.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

103

1129

0.91

0.40

1.7

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.47

0.40

1.6

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

296

1.18

0.40

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

260

0.81

0.40

1.5

2.3

e6/l

323.6

178.0

0.42

142

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.40

0.0

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

486

0.86

0.39

1.4

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

873

1.10

0.39

1.6

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

103

0.68

0.39

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

205

1.22

0.39

1.2

1.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.39

0.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.39

0.0

1.4

—

(3037121) Protein [Mass/volume] in Urine

187

1751

1.07

0.39

3.4

2.8

g/l

0.2

0.3

4.71

694

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

560

1.13

0.38

1.9

2.1

10.8

13.0

0.80

303

(3022689) Creatine [Moles/volume] in Urine

142

1.27

0.38

1.1

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

665

1.11

0.38

4.6

1.5

—

(3036603) Volume of Urine

363

1.16

0.38

1.5

1713.6

2249.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

382

1.15

0.38

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

246

0.81

0.36

1.0

1.1

mg/g

5.1

5.0

0.01

231

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

131

1214

1.08

0.36

3.1

2.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

134

1.27

0.36

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

198

1.21

0.36

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

135

0.74

0.36

1.0

1.1

—

(44790049)

587

0.89

0.36

1.3

1.4

—

(44790047)

587

0.89

0.36

1.3

1.4

—

(44806118)

587

0.89

0.36

1.3

1.4

—

(44790048)

587

0.89

0.36

1.3

1.4

—

(4062490)

818

0.90

0.36

1.4

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

234

0.81

0.35

1.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

233

2207

1.06

0.35

2.1

2.3

160.7

164.8

0.36

223

2077

(3029612) Listeria sp Ab [Titer] in Serum

1.40

0.35

1.7

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.40

0.35

1.0

1.2

—

(4094501)

139

1295

1.07

0.35

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

287

0.84

0.34

1.2

1.1

—

(3024471) HLA-A [Type]

172

1.22

0.34

1.0

—

(3011412) CD3 cells [#/volume] in Blood

690

1.10

0.34

2.6

2.4

e9/l

1.5

1.3

0.30

408

(3005322) IgE [Units/volume] in Serum or Plasma

622

6031

1.03

0.34

1.2

1.3

u/ml

250.0

183.1

0.56

576

5592

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

472

4554

1.04

0.34

2.2

2.3

ml/min/173m2

77.2

77.5

0.06

183

1704

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

128

1375

0.93

0.34

1.1

—

(3042517) Benzodiazepines panel - Urine

154

1.23

0.33

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

754

7749

0.97

0.33

1.5

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

486

4693

1.04

0.33

1.1

titre

72.8

229.0

3.16

121

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

228

1.18

0.33

1.6

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

136

1456

0.93

0.33

1.3

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

199

0.80

0.33

1.1

1.0

u/ml

0.1

1.0

—

133

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

177

0.79

0.33

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.68

0.33

1.2

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.67

0.32

1.0

1.1

—

3.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

397

1.13

0.32

1.1

—

(3044941) Cell count panel - Synovial fluid

721

1.10

0.32

1.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

124

1155

1.07

0.32

1.4

1.3

u/ml

34.0

57.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

209

1982

1.06

0.32

1.1

u/ml

1.6

1.7

0.05

489

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

176

0.80

0.32

1.1

—

(3049717) Cytology report of Urine Cyto stain

103

953

1.08

0.32

2.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

230

0.83

0.31

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

538

0.89

0.31

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

685

1.10

0.31

1.5

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

197

0.81

0.31

2.8

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

197

0.81

0.31

2.7

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

159

1498

1.06

0.30

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

377

3633

1.04

0.30

3.8

3.3

ng/l

80.4

75.0

0.49

347

3250

(3047189) Immunofixation for 24 hour Urine

129

1.24

0.30

1.9

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

151

1603

0.94

0.30

1.0

1.1

u/ml

2.5

2.7

0.11

891

(3028433) Virus identified in Specimen by Culture

203

1.18

0.29

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

534

1.11

0.29

1.5

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

119

1112

1.07

0.29

1.4

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

278

1.15

0.29

1.6

1.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

250

1.16

0.29

1.2

1.4

e6/l

14180.8

3013.7

0.47

173

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

268

2798

0.96

0.29

1.1

u/ml

3.7

4.5

0.28

454

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

179

1696

1.06

0.29

1.8

—

(3042631) Mycobacterium sp identified in Specimen

439

1.12

0.29

2.1

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

104

968

1.08

0.29

1.5

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

151

1600

0.94

0.28

1.5

mmol/l

7.1

6.6

0.69

114

1149

(3030981) Hyaline casts [#/volume] in Urine by Automated count

279

2676

1.04

0.28

2.4

e6/l

0.2

0.10

267

2546

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

162

0.80

0.28

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

584

1.10

0.28

1.8

1.7

47.7

49.6

0.15

359

(3009343) pH of Capillary blood

250

2394

1.05

0.28

3.3

2.7

7.4

0.09

321

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

346

1.13

0.27

1.4

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

118

0.76

0.27

3.8

5.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.23

0.27

10.4

8.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

823

0.92

0.27

1.4

1.2

umol/l

6.0

5.5

0.58

763

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

442

1.11

0.27

1.7

1.6

39.2

40.7

0.09

259

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

875

1.08

0.26

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

113

1.24

0.26

1.1

1.2

—

(1616796) Gas panel - Central venous blood

105

982

1.07

0.26

4.0

2.7

—

(3033799) Differential panel - Peritoneal fluid

104

1.25

0.26

2.3

2.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

241

2311

1.04

0.26

3.2

2.6

mmol/l

1.7

1.3

0.82

175

1607

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.25

0.25

4.1

6.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

277

0.87

0.25

2.7

2.2

ug/l

1.6

1.2

0.33

264

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

273

1.14

0.25

1.1

—

(4015189)

1.18

0.24

2.4

2.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.17

0.24

1.6

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

551

1.09

0.24

1.2

u/l

15.1

21.2

0.85

479

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

609

1.08

0.24

1.1

1.2

—

(3048879) Bone marrow aspiration report

0.73

0.24

2.8

2.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

638

1.08

0.24

1.1

ratio

1.0

1.1

0.03

246

(3034988) Calcium [Moles/volume] in Capillary blood

0.72

0.24

2.8

2.1

mmol/l

1.2

—

(3012441) Differential panel - Pleural fluid

208

1.15

0.24

1.3

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

107

1136

0.94

0.23

1.1

iu/ml

137.8

9114.3

0.63

295

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.28

0.23

1.0

—

(3015183) Erythrocyte sedimentation rate

582

1.08

0.23

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.24

0.22

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

369

0.89

0.22

2.0

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.77

0.22

1.0

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.25

0.22

1.0

1.2

ug/g

286.8

153.2

—

(3002619) Bacteria identified in Specimen by Culture

125

1.20

0.22

1.7

1.1

—

(4034850)

204

2124

0.96

0.22

8.0

7.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

583

1.08

0.22

1.6

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

178

0.84

0.22

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

178

0.84

0.22

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

159

1519

1.05

0.21

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

603

1.08

0.21

2.8

3.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1600

15804

1.02

0.21

1.6

mmol/l

1.4

1.3

0.36

1382

13815

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.19

0.21

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.19

0.21

1.0

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

214

2060

1.04

0.21

1.3

u/ml

46.4

38.0

0.35

210

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

392

1.10

0.21

3.1

2.5

nmol/l

123.6

93.2

0.25

385

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

251

0.88

0.20

2.3

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

731

1.07

0.20

3.4

3.5

u/ml

198.1

555.7

0.48

676

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.1

—

3.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

528

1.08

0.20

1.8

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

328

3187

1.03

0.20

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

122

1161

1.05

0.20

1.1

—

(3017509) Phencyclidine [Presence] in Urine

136

1.18

0.20

1.1

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

132

1259

1.05

0.20

2.3

2.1

ug/l

410.3

328.3

0.22

120

1109

(3034092) Cytoplasmic Ig cells/100 cells in Blood

114

0.79

0.20

5.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

176

0.85

0.19

1.9

1.3

—

(3001556) Androgen free Index in Serum or Plasma

144

0.83

0.19

1.0

1.1

—

(1002224) Polysomnography panel

339

3485

0.97

0.19

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

218

0.87

0.19

3.4

2.7

—

(3024263) Appearance of Synovial fluid

239

0.88

0.19

1.7

2.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

644

6563

0.98

0.19

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

122

0.82

0.19

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

122

0.82

0.19

1.5

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

308

1.10

0.19

1.2

—

(3020491) Glucose [Moles/volume] in Blood

559

1.07

0.19

1.4

1.6

mmol/l

5.8

0.02

455

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

447

0.92

0.19

1.0

1.1

nmol/l

0.1

2.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

249

0.88

0.19

2.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

249

0.88

0.19

2.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

249

0.88

0.19

2.3

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

175

0.86

0.18

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.23

0.18

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

251

1.12

0.18

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

347

1.10

0.18

1.1

1.2

105.5

109.5

0.60

316

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

299

1.10

0.18

1.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

128

1224

1.05

0.18

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

837

0.94

0.18

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

261

2533

1.03

0.18

2.0

2.2

umol/l

4.4

5.0

0.66

186

1839

(40758292) HTLV I+II Ab panel - Serum

100

1.20

0.18

1.2

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

170

1637

1.04

0.18

1.1

u/ml

4.5

3.9

0.22

673

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

620

1.07

0.17

1.2

u/l

55.6

57.3

0.12

415

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

903

1.05

0.17

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

403

0.92

0.17

1.5

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.11

0.17

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

378

1.09

0.17

1.7

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

355

3467

1.03

0.16

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

388

1.08

0.16

2.2

2.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

719

1.06

0.16

1.0

u/ml

1.3

0.7

0.23

160

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

246

0.89

0.16

1.7

1.1

—

(3045716) Anion gap in Serum or Plasma

177

1.13

0.16

8.0

2.2

mmol/l

11.3

9.2

0.85

137

(3014133) Dog dander IgE Ab [Units/volume] in Serum

180

1741

1.03

0.16

1.1

u/ml

3.7

4.4

0.17

658

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.10

0.15

1.3

1.1

—

(3024932) HLA-DR beta [Type]

168

1.13

0.15

1.2

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.76

0.15

1.0

1.1

u/ml

0.3

0.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

303

1.09

0.15

1.8

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

429

1.07

0.15

2.8

mg/l

167.5

59.1

0.40

301

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

136

1411

0.96

0.15

1.2

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

294

1.09

0.14

1.1

1.2

u/l

17.7

17.4

0.03

243

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

312

3050

1.02

0.14

1.3

ug/l

3.9

3.1

0.32

287

2815

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

378

0.93

0.14

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

316

0.92

0.14

1.3

1.1

—

(3000012) Reticulocyte production index

227

1.10

0.14

1.1

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

704

1.05

0.14

1.3

—

(4027681)

675

0.95

0.14

1.3

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

165

1702

0.97

0.14

1.1

1.2

mmol/l

3.5

3.6

0.46

159

1596

(3014271) Vancomycin [Susceptibility]

103

1.17

0.13

1.8

2.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

189

1.11

0.13

2.0

1.7

ug/l

8.0

8.5

0.25

189

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

315

1.08

0.13

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

745

0.95

0.13

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

120

1158

1.04

0.13

1.2

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

126

1304

0.97

0.13

1.4

nmol/l

30.8

31.7

0.14

119

1197

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

138

0.87

0.13

1.0

1.2

—

(3004775) Volume in Urine collected for unspecified duration

273

0.92

0.13

2.5

2.4

594.4

621.9

0.18

218

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

248

1.09

0.12

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

580

0.95

0.12

1.6

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

126

1302

0.97

0.12

1.4

1.3

nmol/l

1.5

1.3

0.35

106

1072

(21494434) Karyotype in Bone marrow

282

0.92

0.12

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

276

2704

1.02

0.12

1.5

nmol/l

0.5

0.32

223

2188

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

415

0.94

0.11

1.3

1.2

63.4

71.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

237

2319

1.02

0.11

1.1

u/ml

0.9

1.1

0.30

867

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

513

1.05

0.11

1.2

titre

219.1

196.8

0.07

102

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

165

1694

0.97

0.11

1.2

1.4

e6/l

704.7

3628.9

0.73

132

1397

(3038177) Helicobacter pylori Ab [Presence] in Serum

158

1623

0.97

0.11

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

435

0.94

0.11

1.0

1.1

90.4

91.6

0.09

357

(3023487) Leukocytes [#/volume] in Peritoneal fluid

124

1.13

0.11

2.5

2.4

e6/l

407.0

786.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

165

1693

0.97

0.11

1.2

1.3

e6/l

86.3

24.0

0.39

128

1326

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1148

11577

0.99

0.11

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

393

0.94

0.10

2.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

393

0.94

0.10

2.0

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

393

0.94

0.10

2.0

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

584

1.04

0.10

1.1

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.11

0.09

1.0

—

(3034770) Mitochondria Ab [Titer] in Serum

195

1909

1.02

0.09

1.3

titre

1291.8

950.7

0.33

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

644

1.04

0.09

1.0

1.1

iu/ml

8.6

7.6

0.18

203

(3022313) Gas panel - Capillary blood

163

1668

0.98

0.09

3.3

2.7

—

(3044927) Protein electrophoresis panel - Urine

281

1.07

0.09

1.3

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

248

0.93

0.09

1.7

1.5

2.4

4.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1245

12536

0.99

0.09

3.9

4.0

mg/mmol

12.3

10.2

0.48

779

7798

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

842

1.03

0.09

1.1

—

(3023410) Appearance of Cerebral spinal fluid

797

0.97

0.09

1.2

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

527

1.04

0.09

1.1

1.2

u/ml

7.0

16.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

213

2091

1.02

0.08

1.0

1.1

u/ml

5.4

4.9

0.18

1082

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

796

0.97

0.08

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

253

1.07

0.08

1.3

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

195

1914

1.02

0.08

1.2

1.3

mg/l

524.0

455.0

0.36

187

1834

(3008401) Mugwort IgE Ab [Units/volume] in Serum

200

1964

1.02

0.08

1.0

1.1

u/ml

1.5

0.9

0.39

802

(3022475) Manganese [Moles/volume] in Blood

0.77

0.08

1.0

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

450

0.96

0.08

1.0

1.1

u/ml

13.1

9.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.08

0.08

1.0

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

705

6991

1.01

0.08

2.0

nmol/l

387.5

376.8

0.77

653

6446

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.03

0.07

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.82

0.07

1.5

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.81

0.07

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.80

0.07

1.3

1.1

—

(3037756) Immunofixation for Serum or Plasma

589

1.04

0.07

2.0

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

398

0.95

0.07

2.0

1.6

nmol/l

1.4

16.6

0.59

325

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

783

0.97

0.07

1.6

1.5

pmol/l

368.9

389.5

0.11

624

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

343

1.05

0.07

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.87

0.07

2.7

2.0

mmol/l

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

367

0.95

0.07

1.3

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.07

0.07

1.2

2.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

255

0.94

0.07

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

387

0.96

0.07

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.12

0.06

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

640

0.97

0.06

1.3

titre

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

472

1.04

0.06

1.6

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

162

1592

1.02

0.06

1.2

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

183

0.93

0.06

1.1

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1201

11949

1.01

0.06

1.6

pmol/l

31831979.4

28013428.5

0.10

1021

10463

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

105

0.86

0.06

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

374

1.04

0.06

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

740

0.97

0.06

2.4

mmol/l

1.4

0.18

721

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

152

0.92

0.06

1.1

1.0

—

(4268621)

992

0.98

0.06

2.1

2.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

147

1495

0.98

0.06

3.3

2.6

mmol/l

24.8

24.7

0.22

140

1396

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

217

1.06

0.06

1.1

—

(3023419) Bacteria identified in Sputum by Culture

494

1.03

0.05

2.4

2.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

139

1.08

0.05

3.5

4.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

146

1438

1.02

0.05

3.2

3.7

u/ml

36.1

26.5

0.51

136

1390

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

171

0.94

0.05

4.4

2.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

323

0.96

0.05

3.7

4.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

524

0.97

0.04

3.0

2.5

e6/l

565.8

509.2

0.60

426

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

824

1.02

0.04

1.5

1.4

—

(4133840)

170

0.94

0.04

1.1

—

(4024509)

517

1.03

0.04

1.2

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

190

1.05

0.04

1.6

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

220

1.05

0.03

1.3

1.4

e6/l

27432.9

79434.4

0.71

119

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

492

0.98

0.03

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

697

1.02

0.03

1.1

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

813

0.98

0.03

1.0

1.1

mg/l

196.0

205.0

0.35

717

(40765096) Chromosome analysis panel by Banding

102

1.08

0.03

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

231

1.04

0.02

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

500

0.98

0.02

1.9

1.6

—

(3013637) Mi-2 Ab [Presence] in Serum

168

0.95

0.02

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

168

0.95

0.02

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

168

0.95

0.02

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

168

0.95

0.02

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

389

3907

1.00

0.02

1.8

1.6

mg/l

3.0

3.4

0.73

257

2682

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

252

1.03

0.02

1.1

1.3

—

965.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

107

0.93

0.02

2.6

2.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

127

0.94

0.01

1.0

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

838

0.99

0.01

1.1

1.2

mg/l

32.0

35.6

0.56

710

(3035637) Corticotropin [Mass/volume] in Plasma

852

1.01

0.01

1.7

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

323

1.02

0.01

1.4

1.6

u/field

1.9

2.4

0.29

236

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

926

9273

1.00

0.01

1.5

—

(44806071)

134

1.04

0.00

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

194

1.03

0.00

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

194

1.03

0.00

1.4

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

246

0.98

0.00

1.2

27.8

14.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

486

0.99

0.00

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

516

0.99

0.00

3.1

2.5

e9/l

0.2

0.26

427

(3036489) Thrombin time

264

2646

1.00

0.00

1.8

1.9

20.6

0.01

219

2210

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

0.98

0.00

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

177

1.02

0.00

3.2

2.2

—

(3019977) pH of Arterial blood

217

1.01

0.00

2.5

3.0

7.4

0.09

(3017704) Immunofixation for Urine

156

1.03

0.00

1.7

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

477

1.01

0.00

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

637

1.00

0.00

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

246

1.02

0.00

1.0

1.1

iu/ml

—

3.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

346

1.01

0.00

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

356

1.01

0.00

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

404

0.99

0.00

1.7

1.8

u/field

5.2

1.9

0.88

206

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

434

0.99

0.00

1.5

1.4

u/l

4.3

5.2

1.86

374

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

164

1643

1.00

0.00

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

754

0.99

0.00

1.9

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

115

0.96

0.00

1.0

1.3

mg/l

0.8

104.0

—

(3004451) EKG impression Narrative

125

1.04

0.00

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

145

0.97

0.00

1.1

—

213.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

103

1035

1.00

0.00

2.9

2.8

nmol/l

0.9

0.8

0.71

872

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

572

1.00

0.00

1.8

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

638

1.00

0.00

1.3

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

231

2308

1.00

0.00

1.9

2.0

93.4

95.5

0.63

216

2107

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

281

1.00

0.00

1.1

1.4

u/ml

12.7

17.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

369

1.00

0.00

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

679

1.00

0.00

2.5

mmol/l

6.8

7.1

0.48

662

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

111

0.99

0.00

2.9

2.2

e6/l

1075.0

23899.0

—

(3044007) Cell count panel - Peritoneal fluid

101

0.99

0.00

3.7

2.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

0.90

0.00

1.5

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.3

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

319.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.92

0.00

1.3

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.98

0.00

1.2

1.4

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.94

0.00

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.99

0.00

1.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

250

1.00

0.00

1.2

nmol/l

6.4

5.6

0.63

236

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.98

0.00

12.3

8.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1398.9

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

5.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

0.91

0.00

1.0

1.2

—

1.3

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.91

0.00

3.0

7.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3027020) Pear IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.5

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.95

0.00

1.3

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CERVICAL_HSIL and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_CERVICAL_HSIL	1.314 [1.17, 1.48]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.045

During the follow-up period (1.1.1998 — 31.12.2019), 1401 out of 43721 females with N14_CERVICAL_HSIL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_CERVICAL_HSIL.

N-year risk	Females	Males
1	0.103%	No data
5	0.634%	No data
10	1.524%	No data
15	3.107%	No data
20	5.718%	No data

Relationships between endpoints

↥

Index endpoint: N14_CERVICAL_HSIL – HSIL lesion of the cervix uteri

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

HSIL lesion of the cervix uteri

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints